Global /South Korea /Healthcare /Biotechnology /086060

GeneBioTech Co. ,Ltd

086060

• KRX: 086060 • Delayed

4,665KRW -2.4%

3.09 USD

As of 18 June 2026, GeneBioTech Co. ,Ltd has a market cap of $26.33M USD, ranking #35134 globally and #2191 in South Korea. It ranks #3177 in the Healthcare sector, and #614 in the Biotechnology industry.

Global Rank

35134

Country Rank

2191

Sector Rank

3177

Industry Rank

614

Key Stats

Market Cap

$26.33MUSD

40.17B KRW

Enterprise Value

$20.03MUSD

30.23B KRW

Revenue (TTM)

$59.52MUSD

90.79B KRW

EBITDA (TTM)

$3.57MUSD

5.38B KRW

Net Income (TTM)

$2.48MUSD

3.79B KRW

EBITDA Margin

5.9%

Profit Margin

4.2%

PE Ratio

10.6

PS Ratio

0.4

PB Ratio

0.7

EV/EBITDA

5.6

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Chan-Ho Lee open_in_new

Employees

Founded

2000

Website

genebiotech.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.4%	-1.4%	-6.1%	11%	19%	19%	39%	11%	-27%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	086060 (주)진바이오텍 ISIN: KR7086060001 Shares Out.: Shares Outstanding: 8.611M¹ Shares Float: 8.611M² TV: TradingView: KRX: 086060 SA: Stock Analysis: KRX: 086060 YF: Yahoo Finance: 086060.KS GF: Google Finance: KRX: 086060 BA: Barron's: 086060 MS: Morningstar: XKRX: 086060	4,665 KRW	TV: TradingView: KRX: 086060 SA: Stock Analysis: KRX: 086060 YF: Yahoo Finance: 086060.KS GF: Google Finance: KRX: 086060 BA: Barron's: 086060 MS: Morningstar: XKRX: 086060

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.7B 68.19T KRW 170K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.03B 42.76T KRW 106K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.33B 20.33T KRW 51K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.49B 8.37T KRW 21K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.98B 6.07T KRW 15K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.25B 3.42T KRW 8K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 693K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 607K%	19.0	United States
argenx SE EBR: ARGX	$48.06B 41.39B EUR 182K%	39.9	Netherlands
Lonza Group AG SIX: LONN	$42.51B 33.71B CHF 161K%	37.2	Switzerland
CSL Ltd. ASX: CSL	$42.44B 60.27B AUD 161K%	29.3	Australia
Natera, Inc. NASDAQ: NTRA	$27.6B 105K%	-	United States

chevron_leftBack